Related by context. All words. (Click for frequent words.) 74 atypical Hemolytic Uremic Syndrome 74 leukemia AML 73 MELAS 72 hypereosinophilic syndrome 72 Ribavirin causes 72 Atypical Hemolytic Uremic Syndrome 72 pulmonary hypertension PH 71 complement inhibitor eculizumab 71 mycosis fungoides 71 metastatic malignant 71 myelodysplastic myeloproliferative diseases 70 NAGS deficiency 70 Severe Primary IGFD 70 TTR amyloidosis 70 ara C 70 lysosomal storage disease 70 invasive candidiasis 70 haematologic 70 sJIA 70 ANCA associated 70 Leber Hereditary Optic Neuropathy 70 chronic immune thrombocytopenic 70 relapsed MM 70 Neovascular Age Related Macular 70 systemic juvenile idiopathic 70 homozygous familial hypercholesterolemia 70 chronic myeloid 70 erythematosus SLE 70 idiopathic PAH 69 essential thrombocythemia ET 69 chronic eosinophilic leukemia 69 Gleevec resistant 69 nephropathic cystinosis 69 Leukemias 69 chronic granulomatous disease 69 myelofibrosis polycythemia vera 69 myeloproliferative disorders 69 gastrointestinal stromal tumors GISTs 69 benign prostatic hypertrophy BPH 69 aflibercept VEGF Trap 69 Eculizumab 69 myeloproliferative 69 kidney urologic 69 idiopathic thrombocytopenic purpura ITP 69 idiopathic thrombocytopenic purpura 69 refractory Hodgkin 69 Chronic Lymphocytic Leukemia CLL 69 orally administered inhibitor 69 Chronic lymphocytic leukemia 69 primary hyperparathyroidism 69 Leber Congenital Amaurosis LCA 69 severe malignant osteopetrosis 69 juvenile idiopathic arthritis JIA 69 Vidaza ® 69 Myelofibrosis 69 Vidaza azacitidine 69 CYT# potent vascular disrupting 69 Aviptadil 69 autosomal dominant polycystic kidney 69 malignant lymphomas 69 ocular disorders 69 Eisenmenger syndrome 69 azacytidine 69 symptomatic benign prostatic 69 esophageal candidiasis 69 Alport syndrome 69 purpura ITP 69 Sezary syndrome 69 Lymphoid 68 refractory chronic lymphocytic 68 candidemia 68 glomerulonephritis 68 Chronic Sinusitis 68 Glioblastoma Multiforme 68 CTAP# 68 Diffuse Large B 68 Nilotinib 68 basal cell nevus syndrome 68 relapsed leukemia 68 Naive Patients 68 erythropoietic 68 Chronic Prostatitis 68 familial amyloidotic polyneuropathy FAP 68 Myelodysplastic Syndrome MDS 68 cystic fibrosis chronic pancreatitis 68 erlotinib Tarceva ® 68 immunodeficiency disorders 68 bullous 68 anterior uveitis 68 MALT lymphoma 68 Mitomycin C 68 Acute Myelogenous Leukemia 68 leukoencephalopathy 68 Cutaneous T 68 G6PD deficiency 68 Investigational Treatment 68 interferon alpha IFN 68 myelodysplastic syndrome MDS 68 Chronic Myeloid Leukemia 68 alpha1 antitrypsin deficiency 68 LHRH receptor positive 68 galiximab 68 autoimmune hemolytic anemia 68 familial hypercholesterolemia FH 68 ocular inflammatory 68 Sjogren Syndrome 68 Epratuzumab 68 HeFH 68 Pseudomonas aeruginosa infections 68 deletion 5q 68 recurrent glioblastoma multiforme 68 Leber congenital amaurosis LCA 68 HBeAg negative 68 orally administered synthetic retinoid 68 malignant ascites 68 Cloretazine 68 Zollinger Ellison Syndrome 68 Paroxysmal Nocturnal Hemoglobinuria PNH 67 gastrointestinal stromal tumor GIST 67 abacavir Ziagen 67 metaplasia 67 Lennox Gastaut Syndrome 67 vWD 67 Cytarabine 67 pretransplant 67 Myelodysplastic Syndrome 67 dasatinib Sprycel 67 LHON 67 essential thrombocythemia 67 gastrointestinal stromal tumor 67 smoldering myeloma 67 relapsed ALL 67 hypocalcaemia 67 SPRYCEL ® 67 TNF Tumor Necrosis Factor 67 Squalamine 67 thalidomide Thalomid 67 monocytic 67 eosinophilic asthma 67 Zollinger Ellison syndrome 67 neovascular diseases 67 bexarotene 67 bladder carcinoma 67 INCB# [003] 67 acute humoral rejection 67 hematological diseases 67 benign neoplasms 67 Personalized Immunotherapy 67 SSc 67 uricase 67 acetonide FA 67 C1 INH deficiency 67 antimetabolite 67 familial hypercholesterolemia 67 hypophosphatasia 67 retinal vein occlusion 67 papillary renal cell carcinoma 67 hematologic disorders 67 autosomal recessive disorder 67 investigational monoclonal antibody 67 Hurler syndrome 67 gastrointestinal stromal tumors GIST 67 NMDA antagonists 67 post transplant lymphoproliferative 67 Progressive Multifocal Leukoencephalopathy 67 Fludarabine 67 lung fibrosis 67 secondary hyperparathyroidism 67 hemolytic anemia 67 imatinib resistant 67 acute GvHD 67 pancytopenia 67 monogenic 67 smoldering multiple myeloma 67 allograft rejection 67 Acute Myeloid Leukaemia AML 67 Carbamazepine 67 Sjögren syndrome 67 Lupus Nephritis 67 Cell Lymphoma 67 constipation predominant irritable bowel 67 Candida infection 67 transthyretin amyloidosis 67 Carcinoid tumors 67 constipation OIC 67 either acutely decompensated 67 cutaneous T 67 dyskeratosis congenita 67 pancreatic insufficiency 67 progressive neurodegenerative 67 systemic amyloidosis 67 choroidal vasculopathy 67 thrombocytosis 67 myeloproliferative diseases 67 Letairis ambrisentan 67 K ras mutations 67 hormone refractory metastatic prostate 67 aHUS 67 anti angiogenic agents 67 paroxysmal nocturnal hemoglobinuria 67 non alcoholic steatohepatitis 66 Von Willebrand disease 66 acute myelogenous leukemia AML 66 hypercalciuria 66 lichen planus 66 Complicated Skin 66 metastatic neuroendocrine tumors 66 imatinib Gleevec 66 pheochromocytoma 66 alkylating 66 systemic anaplastic large 66 SinuNase TM 66 haematological malignancies 66 Philadelphia Chromosome Positive 66 von Hippel Lindau 66 chronic renal disease 66 Enzastaurin 66 pouchitis 66 interstitial nephritis 66 homozygous FH 66 Bronchiectasis 66 Pegylated Interferon 66 myeloid metaplasia 66 Follicular Lymphoma 66 Rituxan rituximab 66 cisplatin gemcitabine 66 hemorrhagic cystitis 66 cytomegalovirus retinitis 66 nitrofurantoin 66 pemphigus vulgaris 66 polycythemia vera essential thrombocythemia 66 sarcomatoid 66 selective modulator 66 Omacetaxine 66 grade cervical intraepithelial 66 MAGE A3 ASCI 66 Interferon Beta 66 Li Fraumeni syndrome 66 Mg Uk 66 Aflibercept 66 MELAS syndrome 66 neuroendocrine cancers 66 imatinib resistance 66 Hodgkin lymphoma NHL 66 Familial Adenomatous Polyposis FAP 66 Ph + acute lymphoblastic 66 anemias 66 cell lymphoma CTCL 66 treats paroxysmal nocturnal 66 etanercept Enbrel 66 endometrial hyperplasia 66 riociguat 66 hypercholesterolaemia 66 sorafenib Nexavar 66 idiopathic pulmonary 66 unresectable tumors 66 RNAi therapeutic targeting 66 acute myeloid 66 Romidepsin 66 choroidal neovascularization 66 erythematosus 66 relapsed Acute Myeloid 66 Relapsed Refractory 66 Hutchinson Gilford progeria 66 hyperphenylalaninemia HPA due 66 decompensated cirrhosis 66 leukemia CML 66 myeloproliferative neoplasms 66 noninfectious uveitis 66 systemic corticosteroid 66 bronchoalveolar 66 demethylating agent 66 psoriasis Crohn disease 66 juvenile idiopathic arthritis 66 T1DM 66 immune modulating 66 metastatic gastric 66 refractory gout 66 subependymal giant cell 66 cytopenias 66 Anti VEGF 66 lysosomal storage disorder 66 vWF 66 Carbidopa 66 visilizumab 66 Systemic lupus erythematosus SLE 66 invasive aspergillosis 66 peritumoral brain edema 66 mixed hyperlipidemia 66 Wiskott Aldrich syndrome 66 MPGN 66 bortezomib Velcade 66 lupus scleroderma 66 Elotuzumab 66 MGd 66 thymic carcinoma 66 GH deficiency 66 von Willebrand 66 PAOD 66 DMARDS 66 Morquio 66 immunodeficiencies 66 multiple sclerosis psoriasis 66 NASH Huntington 66 Pathway Inhibitor 66 antiphospholipid syndrome 66 gastric carcinoma 66 genetic lysosomal storage 66 diabetic kidney 66 hepatorenal syndrome 66 virally induced 66 receptor tyrosine kinase inhibitor 66 Pemphigus 66 Acute Myelogenous Leukemia AML 66 PTLD 66 interstitial pneumonitis 66 Lafora disease 66 Intravenous immunoglobulin 66 Lipodystrophy 66 basiliximab 66 Acute myeloid leukemia AML 65 Soft Tissue Sarcoma 65 Aortic stenosis 65 paraneoplastic 65 nucleoside analogues 65 asplenia 65 refractory acute myeloid 65 included exfoliative dermatitis 65 Acute myeloid leukemia 65 recurrent glioblastoma 65 Azacitidine 65 OHR/AVR# 65 immune dysregulation 65 cilengitide 65 thetreatment 65 ergot derivatives 65 lysosomal storage diseases 65 vinca alkaloid 65 granulomatous 65 receiving immunosuppressive therapy 65 CIMZIA TM certolizumab pegol 65 hepatocellular 65 hypercalcemia 65 leukemia ALL 65 refractory cutaneous T 65 Cell Lymphoma CTCL 65 myeloproliferative neoplasms MPNs 65 Anthracycline 65 prostate carcinomas 65 Lymphocytic 65 Leukine ® 65 Alzheimer Disease AD 65 lymphoid malignancies 65 efalizumab 65 Non Alcoholic Fatty 65 Etanercept 65 epithelial tumors 65 LymphoStat B belimumab 65 nephritis 65 papillary carcinoma 65 T#I [002] 65 Parkinson Disease PD 65 tuberous sclerosis TS 65 Chronic lymphocytic leukemia CLL 65 acute promyelocytic leukemia 65 leukemia CLL 65 Janus kinase 65 diabetic retinopathy DR 65 demonstrated antitumor activity 65 aripiprazole Abilify 65 Vitamin B# deficiency 65 lupus multiple sclerosis 65 systemic fungal infections 65 serologically active systemic lupus 65 cetuximab Erbitux ® 65 novel VDA molecule 65 CDH1 65 overactive bladder syndrome 65 Pegylated 65 sorafenib tablets 65 hepatic encephalopathy HE 65 PNP inhibitor 65 urothelial cancer 65 bevacizumab Avastin ® 65 oral prodrug 65 MYCAMINE 65 imatinib Gleevec ® 65 Campath alemtuzumab 65 Growth Hormone Deficiency 65 tigecycline 65 HQK 65 Hematologic 65 Acute Bacterial Sinusitis ABS 65 PDGFR 65 chronic idiopathic 65 DFMO 65 hemophagocytic lymphohistiocytosis 65 allogeneic HSCT 65 lymphomas leukemias 65 oropharyngeal candidiasis OPC 65 Waldenstrom macroglobulinemia 65 Non Alcoholic Steatohepatitis 65 relapsing remitting MS RRMS 65 severe hypersensitivity reactions 65 Antiangiogenic 65 systemic lupus erythematosus psoriasis 65 gastric adenocarcinoma 65 purpura 65 Adenoviral 65 AML MDS 65 Crohns disease 65 Primary IGFD 65 underlying vasculopathy 65 TNF alpha antagonist 65 generation purine nucleoside 65 Juvenile Idiopathic Arthritis 65 posterior uveitis 65 Chronic Myelogenous Leukemia CML 65 nausea vomiting headache 65 mesangial 65 OMNARIS HFA 65 monoclonal antibody conjugated 65 Heterozygous Familial Hypercholesterolemia 65 Refractory Hodgkin Lymphoma 65 urticaria hives 65 immune thrombocytopenic purpura 65 refractory chronic myeloid 65 JMML 65 denileukin diftitox 65 Friedreich Ataxia FRDA 65 Henoch purpura 65 Primary Hypercholesterolemia 65 degenerative retinal diseases 65 Methylnaltrexone 65 Cytomegalovirus CMV 65 hA# 65 hereditary emphysema 65 vitamin B# folic acid 65 Rheumatoid Arthritis RA 65 hyperparathyroidism 65 SGPT 65 calcineurin inhibitors 65 Dasatinib 65 de novo kidney transplant 65 miglustat 65 hepatic cirrhosis 65 myotonic muscular dystrophy 65 acute lymphoblastic 65 vaso occlusive crisis 65 fibrotic disease 65 fulminant hepatic failure 65 Hemophilia B 65 NOMID 65 PEGylated Fab fragment 65 nonalcoholic steatohepatitis 65 refractory indolent non 65 Toxicities 65 C1q 65 folinic acid 65 Esophagitis 65 Hereditary angioedema HAE 65 Epidermal Growth Factor Receptor 65 Paraplatin ® 65 Chronic Myelogenous Leukemia 65 Hashimoto thyroiditis 65 AGHD 65 transplantation HCT 65 FUSILEV enhances 65 familial adenomatous polyposis 65 Safinamide 65 Sudhir Agrawal D.Phil 65 levodopa carbidopa 65 JAK2 enzyme 65 induced macular edema 65 allogeneic hematopoietic stem cell 65 Orally administered 65 calcineurin inhibitor 65 Alequel 65 haematopoietic 65 Acute Myeloid Leukemia 65 neovascular 65 endothelin receptor 65 phenylketonuria PKU 65 interleukin IL -# 65 histological subtype 65 immunomodulatory therapy 65 Albuferon TM 65 CTAP# Capsules 65 Bisphosphonate 65 herpes zoster shingles 65 Non Hodgkin 65 Gleevec imatinib mesylate 65 BARACLUDE ® 65 MKC# MT 65 Systemic lupus erythematosus 65 Squamous 65 Central Retinal Vein 65 immuno modulatory 65 Fludara ® 65 oral Janus kinase 65 hematopoietic cancers 65 polycythemia vera PV 65 autoinflammatory diseases 65 Acute Myeloid Leukemia AML 65 PKC# 65 Phenylketonuria PKU 65 mastocytosis 65 keloid scarring 65 trastuzumab Herceptin ® 65 lupus erythematosus 65 5q deletion 65 Dacogen decitabine 65 Kinoid 65 Patients Receiving 65 ADPKD 65 serum phosphate 65 hepatocellular carcinomas 65 mTOR mammalian target 65 cytomegalovirus infection 65 CLL SLL 65 Noxafil 65 myelogenous leukemia 65 pan HDAC inhibitor 65 cysteamine bitartrate 65 Chronic Myeloid Leukemia CML 65 haematologic malignancies 65 quetiapine Seroquel 65 alpha interferons 65 autoimmune thyroiditis 64 infantile spasms IS 64 thalassemia sickle cell 64 psychiatric disorders ATI 64 Bullous 64 congenital ichthyosis 64 Amgen Neulasta R 64 juvenile myelomonocytic leukemia 64 gefitinib Iressa 64 Neovascularization 64 Epstein Barr Virus EBV 64 murine model 64 Retinitis Pigmentosa RP 64 proliferative disorders 64 progressive dyspnea 64 basal cell carcinoma BCC 64 pediatric acute lymphoblastic 64 β thalassemia 64 Haptoglobin 64 TNF antagonist 64 potentially hepatotoxic 64 non metastatic osteosarcoma 64 gastrointestinal dysfunction 64 diabetic gastroparesis 64 Panzem R 64 haemolytic anemia 64 immunomodulatory properties 64 Papillary 64 Leydig cell 64 Sclerosing 64 p# MAP kinase inhibitor 64 Tyrosine Kinase Inhibitors 64 liposomal amphotericin B 64 Ischemic 64 HER2 overexpression 64 Medulloblastoma 64 primary immunodeficiency PI 64 hereditary predisposition 64 diarrhea vomiting rash 64 non splenectomized 64 Factor XIII 64 Stargardt Macular Dystrophy 64 Hypercholesterolemia 64 fluconazole resistant 64 Associated Adipose Redistribution 64 HLA DRB1 * 64 B Cell Lymphoma 64 valvular heart disease 64 pathologic myopia 64 acute mania 64 Pneumocystis carinii pneumonia 64 R Saizen R 64 recessive dystrophic epidermolysis bullosa 64 carcinoid syndrome 64 Tolvaptan 64 autoimmune uveitis 64 Polyneuropathy 64 rheumatoid arthritis psoriatic arthritis 64 Hodgkin lymphoma HL 64 interstitial cystitis IC 64 ABCB1 64 Angioedema 64 dysmotility 64 muscular dystrophy cystic fibrosis 64 Annamycin 64 mTOR inhibitors 64 hypercoagulable 64 Factor Receptor 64 Plaquenil 64 nucleoside analog 64 urothelial carcinoma 64 idarubicin 64 Neurofibromatosis type 64 LPLD 64 Diabetic Macular Edema 64 pharmacokinetic interactions 64 Wegener granulomatosis 64 venous stasis ulcers 64 Epstein Barr Virus 64 patientswith 64 alefacept 64 Lubiprostone 64 flavopiridol 64 precancerous condition 64 griseofulvin 64 INSPIRE Trial Phase III 64 Abrupt discontinuation 64 rheumatoid arthritis inflammatory bowel 64 biliary tract cancer 64 treat benign prostatic 64 SNT-MC#/idebenone 64 lymphoproliferative disease 64 Fibroblasts 64 cancer mCRC 64 cetuximab Erbitux R 64 osteosarcomas 64 Initiate Clinical Trial 64 Liprotamase 64 EGFR inhibitors 64 sitaxsentan 64 cerebri 64 hyperprolactinemia 64 Stargardt Macular Dystrophy SMD 64 polymicrobial infections 64 receiving VELCADE 64 beta 1a 64 heparin induced thrombocytopenia 64 inhibitor RG# 64 Fluorouracil 64 Idiopathic Pulmonary Fibrosis 64 systemic mastocytosis 64 primary ciliary dyskinesia 64 IV Busulfex 64 de novo AML 64 Gorlin syndrome 64 pancreatic neuroendocrine tumors 64 prostate carcinoma 64 opioid induced constipation OIC 64 idiopathic membranous nephropathy 64 decompensated liver disease 64 Idiopathic Pulmonary Fibrosis IPF 64 prokinetic agent 64 Pemetrexed 64 torsade de pointes 64 Pegloticase 64 invasive fungal infection 64 cMET 64 diarrhea predominant irritable 64 Improves Outcomes 64 echinocandin 64 Prolongs Survival 64 leukemias lymphomas 64 anticancer therapy 64 Keratitis 64 nonischemic 64 constipation predominant IBS 64 juvenile myoclonic epilepsy 64 p# inhibitor 64 Candidiasis 64 Gamunex C 64 erythema nodosum 64 macular edema secondary 64 dasatinib Sprycel ® 64 Surgical resection 64 potassium binder 64 weekly subcutaneous injections 64 Crohn disease CD 64 Multiple Myeloma MM 64 Peginterferon alfa 2b 64 cutaneous lupus 64 autosomal recessive disease 64 demyelinating disease 64 Platinol ® 64 inherited metabolic disorders 64 interstitial fibrosis 64 systemic autoimmune 64 lysosomal enzyme iduronate 64 Huntingtons disease 64 pancreatic carcinoma 64 alkylating agent 64 Cryopyrin Associated Periodic Syndromes 64 acute porphyria 64 MGUS 64 vaginal candidiasis 64 deep venous thromboses 64 CDK inhibitor 64 Degarelix 64 polycystic kidneys 64 Anaplastic 64 xeroderma pigmentosum 64 Factor VIIa 64 iobenguane 64 Microplasmin 64 IL# PE#QQR 64 overt nephropathy 64 targeted nucleotide prodrug 64 Nebulized 64 psoriasis rheumatoid arthritis 64 eosinophilic pneumonia 64 undergoing peritoneal dialysis 64 Temsirolimus 64 myocardial infarction ventricular fibrillation 64 Myelodysplastic Syndromes 64 tumor lysis syndrome 64 HMG CoA reductase inhibitors 64 lymphocytic leukemia 64 Angiotensin Converting Enzyme 64 lupus nephritis 64 Lennox Gastaut syndrome 64 intravenous immunoglobulin IVIg 64 diagnostic biomarker 64 metastatic GIST 64 maximally tolerated lipid lowering 64 Hurthle cell 64 Acute Renal Failure 64 Sanfilippo Syndrome 64 induce orthostatic hypotension 64 Lenalidomide 64 endothelial activation 64 systemic lupus erythematosus SLE 64 adenomatous 64 hematological malignancy 64 immunomodulation 64 hyperoxaluria 64 antithymocyte globulin 64 anemia neutropenia 64 metastatic renal 64 Juvenile Idiopathic Arthritis JIA 64 Neovascular AMD 64 Hereditary angioedema 64 refractory NSCLC 64 transaminase elevations 64 iduronate 2 64 Chemokine Receptor 64 hyperplasia BPH 64 Combination therapy 64 myelodysplasia 64 NS5B polymerase 64 cIAI 64 Hypertrophy 64 inhaled bronchodilators 64 corticosteroid therapy 64 mTOR inhibitor 64 Irritable Bowel Syndrome IBS 64 Lenocta 64 AA amyloidosis 64 small molecule activators 64 Fabry Disease 64 Respiratory Syncytial Virus RSV 64 chemotherapy cisplatin 64 hoFH 64 prescribed proton pump 64 metastatic bladder 64 indolent follicular non 64 fibrosing 64 TNF alpha selectively neutralizing 64 memantine Namenda 64 cediranib 64 PsA 64 Xanafide 64 metastatic colorectal 64 ® lenalidomide 64 Darinaparsin 64 relapsed ovarian cancer 64 reslizumab 64 Enbrel Humira 64 Valproic acid 64 pancreatic NET 64 nutlin 3a 64 undergoing hematopoietic stem 64 paraganglioma 64 Adjunctive 64 induced anemia 64 hepatic enzyme 64 dopamine D2 64 retinal vein occlusion induced 64 MTP inhibitor 64 Intravitreal 64 infliximab Remicade 64 corticosteroid dexamethasone 64 AA Amyloidosis 64 Tasigna nilotinib 64 metaglidasen 64 bronchodilatory 64 neutropenia thrombocytopenia 64 bronchopulmonary dysplasia BPD 64 adalimumab Humira 64 arterial thrombosis 64 Imatinib mesylate 64 Glucocorticoid 64 SNT MC# 64 bronchial hyperresponsiveness 64 chronic GVHD 64 Teriflunomide 64 coagulation abnormalities 64 infectious diseases autoimmune diseases 64 chronic obstructive airway 64 post herpetic 64 urolithiasis 64 papular 64 hyper IgE syndrome 64 vidofludimus 64 vinca alkaloids 63 GISTs 63 relapsed AML 63 tyrosine kinase inhibitor TKI 63 thrombocytopenic 63 hepatic lipase 63 Patients Treated With 63 CP CPPS 63 Familial Hypercholesterolemia 63 orchitis 63 inherited neurodegenerative 63 Systemic Juvenile Idiopathic 63 pathophysiological effects 63 Venous thromboembolism 63 systemic lupus erythematosus 63 Tocilizumab 63 PROCRIT ® 63 Bucindolol 63 R lenalidomide 63 sargramostim 63 Li Fraumeni 63 immunopathology 63 diabetic peripheral neuropathy DPN 63 multisystem disease 63 vesicoureteral reflux VUR 63 dermatologic reactions 63 syngeneic 63 Beta thalassemia 63 liver scarring 63 sodium stibogluconate 63 osteopetrosis 63 SOD1 gene 63 secondary amenorrhea 63 acute leukemias 63 Amyloid 63 cholangiocarcinoma 63 carcinoid 63 toenail onychomycosis 63 5 fluorouracil leucovorin 63 Leber congenital amaurosis 63 Zorbtive TM 63 cardiotoxic 63 haematological cancers 63 Renal Impairment 63 hypokalemia hypomagnesemia 63 disease GERD 63 immune thrombocytopenic purpura ITP 63 Subtypes 63 chronic lymphocytic 63 collagen vascular 63 Rilonacept 63 Chronic pancreatitis 63 interferon IFN 63 HepDirect prodrug 63 Antitumor Activity 63 cervical lymph nodes 63 infantile onset 63 MYLOTARG 63 rheumatoid arthritis lupus 63 transgenic rats 63 Enzyme Replacement Therapy 63 enterocolitis 63 intracranial hypertension 63 humanised monoclonal antibody 63 Silodosin 63 convulsive disorders 63 headache abdominal pain 63 antibody mediated rejection 63 dilated cardiomyopathy DCM 63 KRAS oncogene 63 renal cell carcinomas 63 amnestic 63 mucinous 63 schizophrenia CIAS 63 hypertrichosis occurred 63 transplantation HSCT 63 systemic scleroderma 63 peritoneal carcinomatosis 63 LRAT 63 vitreous floaters 63 Denufosol 63 non hodgkin lymphoma 63 MyVax R 63 relapsing multiple sclerosis 63 MyVax ® 63 itraconazole Sporanox 63 Psoriatic arthritis 63 Elevated serum 63 arthropathy 63 cholestasis 63 anthracyclines taxanes 63 chronic myocardial ischemia 63 chronic thromboembolic pulmonary 63 Hormone Refractory Prostate Cancer 63 TTR gene 63 ALK inhibitor 63 tumor xenograft models 63 bone marrow suppression 63 Idiopathic Thrombocytopenic Purpura ITP 63 thyroiditis 63 Sprycel dasatinib 63 treating neuropathic pain 63 exocrine pancreatic insufficiency EPI 63 geographic atrophy 63 dihydrochloride 63 Muraglitazar 63 antibody MAb 63 gastrointestinal stromal tumors 63 hematopoietic cell 63 p# biomarker 63 Systemic Sclerosis 63 atypical neuroleptics 63 Candida infections 63 resectable pancreatic cancer 63 alpha1 antitrypsin AAT deficiency 63 STELARA ™ 63 fungoides 63 narcolepsy cataplexy 63 ELACYT 63 lenalidomide Revlimid R 63 potassium sparing diuretics 63 nephrotoxicity 63 VEGF inhibitors 63 non constipating irritable 63 Secondary Hyperparathyroidism 63 neuropathic pain spasticity 63 Gleevec imatinib 63 sertraline Zoloft 63 monozygotic twin 63 Endometrial 63 Navelbine ® 63 epithelioid 63 optica 63 Relapsing remitting MS 63 carcinoid tumors 63 cheilitis 63 Tumor Necrosis Factor 63 Helicobacter pylori eradication 63 cortical dysplasia 63 rituximab Rituxan 63 protein tyrosine phosphatase 1B 63 Host Disease 63 cisplatin chemotherapy 63 cromolyn sodium 63 tumorigenicity 63 Motavizumab 63 Hepatocellular Carcinoma HCC 63 OMP #R# 63 targeted antifolate 63 follicular lymphoma FL 63 GRNOPC1 contains 63 #beta HSD1 63 Tasimelteon 63 BH4 deficiency 63 cisplatin resistant 63 topically administered 63 nonalcoholic steatohepatitis NASH 63 Niemann Pick disease 63 Tyrosine Kinase Inhibitor 63 sunitinib malate 63 Legg Calvé Perthes disease 63 cause cardiac channelopathies 63 Acne Rosacea 63 hypercalcaemia 63 bevacizumab Avastin R 63 paclitaxel Taxol 63 Mouse Model 63 Hepatic Encephalopathy 63 targeted radiotherapeutic 63 arteritis 63 idiopathic generalized epilepsy 63 cystic kidney 63 Phenylketonuria 63 HoFH 63 proliferative diabetic retinopathy 63 B CLL 63 extramedullary 63 steroid refractory 63 Deforolimus 63 neuroendocrine carcinoma 63 cholelithiasis 63 Daclizumab 63 oral anti arrhythmic 63 chronic idiopathic urticaria 63 acyclovir Zovirax 63 retinitis 63 pathological hallmark 63 membranous nephritis 63 fallopian tube carcinoma